Pfizer reportedly aims to market OTC Lipitor after patent expires

Pfizer is considering launching a nonprescription form of blockbuster cholesterol-lowering drug Lipitor after a key patent expires in November, sources said. However, Pfizer is expected to have trouble doing so because of the FDA's concern that patients will misuse statins without medical guidance.

View Full Article in:

New York Times (tiered subscription model), The · Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN